MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
41 hedge funds and large institutions have $30M invested in Merrimack Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
43% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 14
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
41
Holding in Top 10
1
Calls
$203K
Puts
$135K
Top Buyers
| 1 | +$2.87M | |
| 2 | +$77K | |
| 3 | +$34.1K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$14.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.8K |
Top Sellers
| 1 | -$3.44M | |
| 2 | -$364K | |
| 3 | -$232K | |
| 4 |
LPIC
LeJeune Puetz Investment Counsel
Traverse City,
Michigan
|
-$110K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$102K |